Abstract: An energy-saving control method includes obtaining a demand instruction configured to indicate an energy-saving operation and a performing time slot of the energy-saving operation. The energy-saving operation is determined based on load data of a power grid and is configured to reduce a load of the power grid. The method further includes transmitting a first control message configured to control an authorized device to perform the energy-saving operation in response to detecting that time reaches the performing time slot, and transmitting a second control message configured to control the authorized device to stop performing the energy-saving operation in response to detecting that time is outside the performing time slot.

Abstract: The present application discloses an air conditioner control method. The method includes obtaining a position of a user; detecting that the position of the user meets a preset condition, and obtaining a target operating parameter of an air conditioner, the preset condition being determined according to a preset running time span, and the preset running time span being determined according to a current environmental parameter and a target environmental parameter, and the current environmental parameter comprising at least one of a current indoor temperature, a current indoor humidity, a current air cleanliness and a current air freshness; and controlling the air conditioner at a target position to operate with the target operating parameter. The present application also discloses an air conditioner, a server and a computer readable storage medium.

Abstract: A running control method includes determining a remaining running space of a first household appliance, receiving a remaining running space sent by a second household appliance connected with the first household appliance in an Internet of Things, and determining one of the second household appliance and the first household appliance having the remaining running space meeting a preset remaining running space condition as a control-side household appliance.

Abstract: A running control method includes determining a remaining running space of a first household appliance, receiving a remaining running space sent by a second household appliance connected with the first household appliance in an Internet of Things, and determining one of the second household appliance and the first household appliance having the remaining running space meeting a preset remaining running space condition as a control-side household appliance.

Abstract: The present invention relates to piperazine substituted cyclohexane-1,4-diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as ?1a/?1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.

Abstract: The present invention relates to piperidine substituted cyclohexane-1,4-diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as ?1a/?1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as method of treatments.

Abstract: The present invention relates to piperazine substituted cyclohexane- 1,4-diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as ?1a/?1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.

Abstract: The present invention relates to piperidine substituted cyclohexane-1,4-diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as ?1a/?1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as method of treatments.